| Identification | |
| Name: | 3,5-Pyridinedicarboxylicacid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 3-methyl ester, (4R)- |
| Synonyms: | 3,5-Pyridinedicarboxylicacid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, monomethyl ester, (4R)-(9CI); 3,5-Pyridinedicarboxylic acid,1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, monomethyl ester, (R)-;(-)-(4R)-1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylicacid monomethyl ester; (-)-1,4-Dihydro-5-(methoxycarbonyl)-2,6-dimethyl-4-(3-nitrophenyl)-3-pyridinecarboxylicacid;(R)-5-(Methoxycarbonyl)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydro-3-pyridinecarboxylicacid |
| CAS: | 76093-33-9 |
| Molecular Formula: | C16H16 N2 O6 |
| Molecular Weight: | 0 |
| InChI: | InChI=1/C16H16N2O6/c1-8-12(15(19)20)14(13(9(2)17-8)16(21)24-3)10-5-4-6-11(7-10)18(22)23/h4-7,14,17H,1-3H3,(H,19,20)/t14-/m1/s1 |
| Molecular Structure: |  |
| Properties | |
| Flash Point: | 259.2°C |
| Boiling Point: | 505°C at 760 mmHg |
| Density: | 1.345g/cm3 |
| Refractive index: | 1.587 |
| Flash Point: | 259.2°C |
| Usage: | 1,4-Dihydropyridine derivative used in the prevention and therapy of atherosclerotic degradation of arterial walls |
| Safety Data | |
 |
|
